Clinical observation of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia
HE You-zuo
Abstract
HE You-zuo
Abstract
Objective:To investigate the curative effect of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia.Methods:120 patients with type 2 diabetes with hyperlipemia were randomly divided into three groups,namely simvastatin group,fenofibrate group and simvastatin and fenofibrate group;their results were observed respectively after administration.Results:After treatment,the serum levels of TC,LDL-C and TG in each group all decreased,while the serum level of HDL-C increased.The ranges of decreased level of serum TC,LDL-C and TG and increased level of serum HDL-C in simvastatin and fenofibrate group were all higher compared with those in two drugs used alone.Conclusion:The curative effect of simvastatin combined with fenofibrate in type 2 diabetes with hyperlipemia is satisfactory.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the curative effect of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia.Methods:120 patients with type 2 diabetes with hyperlipemia were randomly divided into three groups,namely simvastatin group,fenofibrate group and simvastatin and fenofibrate group;their results were observed respectively after administration.Results:After treatment,the serum levels of TC,LDL-C and TG in each group all decreased,while the serum level of HDL-C increased.The ranges of decreased level of serum TC,LDL-C and TG and increased level of serum HDL-C in simvastatin and fenofibrate group were all higher compared with those in two drugs used alone.Conclusion:The curative effect of simvastatin combined with fenofibrate in type 2 diabetes with hyperlipemia is satisfactory.
Key concepts: Fenofibrate, Simvastatin, Medicine, Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology, Gastroenterology